CC
CL icon

Callan Capital’s Colgate-Palmolive CL Stock Holding History

Callan Capital’s Portfolio CL Stock Details CL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		$289K Buy
3,086
+740
+32% +$66.3K 0.02% 294
2024
Q4 		$213K Sell
2,346
-151
-6% -$14.4K 0.02% 312
2024
Q3 		$259K Buy
2,497
+168
+7% +$17.1K 0.02% 287
2024
Q2 		$226K Buy
+2,329
New +$215K 0.02% 285

Other funds holding CL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return

Callan Capital's CL Position: Q1 2025 in Review

Callan Capital increased its Colgate-Palmolive (CL) stake by 32% in Q1 2025, buying an estimated $66.3K and bringing the position to 3,086 shares worth $289K. The position accounts for 0.02% of the portfolio, ranked #294.

Callan Capital first reported a position in CL in Q2 2024 and has held it in 4 quarters since. 1,945 funds tracked by Wall St. Rank hold CL as of Q1 2025.

  • Callan Capital held 3,086 shares of Colgate-Palmolive worth $289K as of Q1 2025.
  • Callan Capital bought 740 Colgate-Palmolive shares in Q1 2025, an estimated $66.3K.
  • Colgate-Palmolive made up 0.02% of Callan Capital's portfolio in Q1 2025, its #294 holding.
  • Callan Capital first reported a position in Colgate-Palmolive in Q2 2024 and has held it in 4 quarters since.
  • 1,945 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2025.

Based on Callan Capital's 13F filing for Q1 2025, filed 29 Apr 2025.